Page last updated: 2024-10-25

ciprofloxacin and Depressive Disorder, Major

ciprofloxacin has been researched along with Depressive Disorder, Major in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markowitz, JS1
DeVane, CL1

Other Studies

1 other study available for ciprofloxacin and Depressive Disorder, Major

ArticleYear
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:3

    Topics: Anti-Infective Agents; Antipsychotic Agents; Benzodiazepines; Ciprofloxacin; Cytochrome P-450 CYP1A2

1999